BMO Capital analyst John Kim downgrades Apartment Income REIT (NYSE:AIRC) from Market Perform to Underperform and announces $43 price target.
Goldman Sachs Maintains Sell on 10x Genomics, Lowers Price Target to $25
Goldman Sachs analyst Matthew Sykes maintains 10x Genomics (NASDAQ:TXG) with a Sell and lowers the price target from $35 to $25.